Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
Genetics in Medicine Open
|
February 10, 2025
Biallelic <i>SLC13A1</i> loss-of-function variants result in impaired sulfate transport and skeletal phenotypes, including short stature, scoliosis, and skeletal dysplasia
Christina G Tise, Katie Ashton, Lachlan de Hayr, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 27, 2021
Germline Saturation Mutagenesis Induces Skeletal Phenotypes in Mice
Jonathan J Rios, Kristin Denton, Jamie Russell, et al.
American Journal of Human Genetics
|
November 4, 2023
RAB1A haploinsufficiency phenocopies the 2p14-p15 microdeletion and is associated with impaired neuronal differentiation
Jonathan J Rios, Yang Li, Nandina Paria, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2023
Association of genetic variation in
Hao Yu, Anas M Khanshour, Aki Ushiki, et al.
Elife
|
January 26, 2024
Association of genetic variation in <i>COL11A1</i> with adolescent idiopathic scoliosis
Hao Yu, Anas M Khanshour, Aki Ushiki, et al.
The Journal of Clinical Investigation
|
November 14, 2023
Impaired glycine neurotransmission causes adolescent idiopathic scoliosis
Xiaolu Wang, Ming Yue, Jason Pui Yin Cheung, et al.
Human Molecular Genetics
|
November 6, 2018
Genome-wide meta-analysis and replication studies in multiple ethnicities identify novel adolescent idiopathic scoliosis susceptibility loci
Anas M Khanshour, Ikuyo Kou, Yanhui Fan, et al.
Nature Immunology
|
March 29, 2016
DNA polymerase-α regulates the activation of type I interferons through cytosolic RNA:DNA synthesis
Petro Starokadomskyy, Terry Gemelli, Jonathan J Rios, et al.
Human Mutation
|
September 1, 2019
TBX6 missense variants expand the mutational spectrum in a non-Mendelian inheritance disease
Weisheng Chen, Jiachen Lin, Lianlei Wang, et al.
Neuro-Oncology
|
July 5, 2022
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus
Peter M K de Blank, Andrea M Gross, Srivandana Akshintala, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
Genetics in Medicine Open
|
February 10, 2025
Biallelic <i>SLC13A1</i> loss-of-function variants result in impaired sulfate transport and skeletal phenotypes, including short stature, scoliosis, and skeletal dysplasia
Christina G Tise, Katie Ashton, Lachlan de Hayr, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 27, 2021
Germline Saturation Mutagenesis Induces Skeletal Phenotypes in Mice
Jonathan J Rios, Kristin Denton, Jamie Russell, et al.
American Journal of Human Genetics
|
November 4, 2023
RAB1A haploinsufficiency phenocopies the 2p14-p15 microdeletion and is associated with impaired neuronal differentiation
Jonathan J Rios, Yang Li, Nandina Paria, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2023
Association of genetic variation in
Hao Yu, Anas M Khanshour, Aki Ushiki, et al.
Elife
|
January 26, 2024
Association of genetic variation in <i>COL11A1</i> with adolescent idiopathic scoliosis
Hao Yu, Anas M Khanshour, Aki Ushiki, et al.
The Journal of Clinical Investigation
|
November 14, 2023
Impaired glycine neurotransmission causes adolescent idiopathic scoliosis
Xiaolu Wang, Ming Yue, Jason Pui Yin Cheung, et al.
Human Molecular Genetics
|
November 6, 2018
Genome-wide meta-analysis and replication studies in multiple ethnicities identify novel adolescent idiopathic scoliosis susceptibility loci
Anas M Khanshour, Ikuyo Kou, Yanhui Fan, et al.
Nature Immunology
|
March 29, 2016
DNA polymerase-α regulates the activation of type I interferons through cytosolic RNA:DNA synthesis
Petro Starokadomskyy, Terry Gemelli, Jonathan J Rios, et al.
Human Mutation
|
September 1, 2019
TBX6 missense variants expand the mutational spectrum in a non-Mendelian inheritance disease
Weisheng Chen, Jiachen Lin, Lianlei Wang, et al.
Neuro-Oncology
|
July 5, 2022
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus
Peter M K de Blank, Andrea M Gross, Srivandana Akshintala, et al.
Page
of 6